MLXIPL and malignant colon neoplasm: The reasoning to explore the ChREBP expression in colon cancer is that disturbed glucose and lipid metabolism patients show a higher prevalence of colon cancer14,15, and these metabolic pathways are strongly regulated by the transcription factor ChREBP.